$KBLB

Kraig Biocraft Laboratories (KBLB) applied to expand its Prodigy Silk subsidiary's investment licence to boost spider silk production capacity. The company reported record output, with August production exceeding 30% more than June's 2.5 metric tons. Kraig shipped its first custom spider silk yarn for performance sportswear, marking progress toward commercial applications. Key uncertainties include investment approvals, funding, and converting customer interest into recurring orders.

Kraig Biocraft Laboratories announced all three production centers are operational and commercial deliveries have begun, including a shipment to a sportswear brand. This marks initial commercialization after years of development, with potential catalysts being order sizes, contracts, and revenue data.